Tevogen (TVGN) Treasury Shares (2021 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Treasury Shares came in at $605465.0 in Q1 2026, up 39.32% YoY from $434585.0 in Q1 2025, and down 2.31% on a QoQ basis from $619793.0 in Q4 2025.
Tevogen (TVGN) Treasury Shares (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 6 years of Treasury Shares data on file, last reported at $605465.0 in Q1 2026.
- Quarterly Treasury Shares rose 39.32% year-over-year to $605465.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $605465.0 (up 39.32% YoY) and the FY2025 annual result came in at $619793.0, up 16.11% from the prior year.
- Treasury Shares declined to $605465.0 in Q1 2026, from $619793.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $34.5 million in Q1 2022 to a low of $218002.0 in Q4 2023.
- A 5-year average of $12.9 million and a median of $6.7 million in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares plunged 97.8% — and 2024, when it soared 748.82%.
- Tracing TVGN's Treasury Shares over 5 years: stood at $9.9 million in 2022, then slumped by 97.8% to $218002.0 in 2023, then soared by 144.86% to $533805.0 in 2024, then grew by 16.11% to $619793.0 in 2025, then slipped by 2.31% to $605465.0 in 2026.
- The last three Treasury Shares figures came in at $605465.0 (Q1 2026), $619793.0 (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Tevogen | 25.62 Mn | 25.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 640,082.00 |
| Jun 30, 2026 | 640,082.00 |
| Mar 31, 2026 | 605,465.00 |
| Mar 31, 2026 | 605,465.00 |
| Dec 31, 2025 | 619,793.00 |
| Dec 31, 2025 | 619,793.00 |
| Sep 30, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 31.08 Mn |
| Jun 30, 2025 | 31.08 Mn |
| Mar 31, 2025 | 434,585.00 |
| Mar 31, 2025 | 434,585.00 |
| Dec 31, 2024 | 533,805.00 |
| Dec 31, 2024 | 533,805.00 |
| Sep 30, 2024 | 20.23 Mn |
| Sep 30, 2024 | 20.23 Mn |
| Jun 30, 2024 | 19.35 Mn |
| Jun 30, 2024 | 19.35 Mn |
| Mar 31, 2024 | 19.35 Mn |
| Mar 31, 2024 | 19.35 Mn |